Healthcare Legislation Updates and AI in Health Policy
This week, the U.S. House of Representatives is in a district work period, while the Senate focuses on committee-level oversight. Recently, the House approved a reconciliation package targeting immigration enforcement. Meanwhile, the Senate’s Health, Education, Labor, and Pensions (HELP) Committee is evaluating the role of artificial intelligence in education and will soon convene for healthcare legislation discussions.
The Department of Health and Human Services (HHS) is hosting policy meetings, including one by the Physician-Focused Payment Model Technical Advisory Committee. These discussions focus on patient safety and value-based care, aiming to guide the next National Action Plan for Combating Antibiotic-Resistant Bacteria.
With midterms approaching, legislative days are becoming limited, directing attention to committee actions for progress on health policies. The House Appropriations Committee has moved forward with the fiscal year 2027 Labor-HHS bill, which awaits consideration by the full House.
The Centers for Medicare & Medicaid Services (CMS) launched the Office of Health Technology and Products (OHTP). This office is dedicated to healthcare technology modernization, including initiatives related to artificial intelligence and stakeholder collaboration for improved digital services.
The Food and Drug Administration (FDA) is seeking information about the repurposing of drugs for unmet medical needs, alongside guidance on scale-up and post-approval changes. Public comments on these topics are welcome.
Reports from the Medicare and Social Security Trust Funds point to continuing solvency challenges, highlighting projected fund depletion dates. These reports reflect legislative impacts, including changes to income tax from recent laws.
CMS proposed a rule to refine drug pricing strategies within the Medicare Drug Price Negotiation Program, seeking public feedback by mid-August 2026. A final rule by CMS establishes performance standards for accrediting organizations, impacting Medicare and Medicaid provider participation. Simultaneously, CMS issued Medicaid budget neutrality standards for Section 1115 demonstrations to ensure fiscal compliance.
The Health Resources and Services Administration (HRSA) plans to collect data from drug manufacturers to improve the 340B Rebate Model Pilot Program’s integrity. HHS is also seeking public input on Healthy People 2030 objectives, particularly around screen time goals due to technological advancements.
A federal judge vacated parts of the 2025 final rule regarding the Patient Protection and Affordable Care Act. The ruling, impacting enrollment processes and income verification methods, might lead to an appeal from the administration.